CNMD - コンメド (CONMED Corporation) コンメド

 CNMDのチャート


 CNMDの企業情報

symbol CNMD
会社名 Conmed Corp. (コンメド)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 コンメッド(CONMED Corporation)は医療技術会社である。同社は外科用機器および関連機器の開発、製造および販売に従事する。同社は低侵襲性治療用外科用器具を提供する。同社の製品は整形外科、一般外科、婦人科、脳神経外科、胃腸病学などの専門分野で外科医・医師に使用される。同社の製品ラインは整形外科手術、一般外科手術、手術視覚化を含む。同社の整形外科用製品ラインにはスポーツ医学、動力付き外科用器具、スポーツ用の生物製剤と組織が含まれる。同社の製品は「Hall」、「CONMED Linvatec」、「Concept」、「Shutt」を含むブランドで販売される。   コンメドは米国の手術器具や装置に特化した大手医療品メ―カ―。内視鏡などの腹腔鏡手術や、そのほかの整形外科市場向けの受電手術器具、心臓モニタリング及び血液酸素化モニタリング用ECG電極製品、手術用電動ノコギリ、ドリル、発電機などを提供する。本社はニューヨーク州ウティカ。   CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its product lines also include orthopedic surgey and general surgery. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Utica, NY.
本社所在地 525 French Road Utica NY 13502 USA
代表者氏名 Mark E. Tryniski マークE.トゥリニスキ
代表者役職名 Independent Chairman of the Board
電話番号 +1 315-624-3215
設立年月日 25600
市場名 NASDAQ National Market System
ipoyear 1987年
従業員数 3100人
url www.conmed.com
nasdaq_url https://www.nasdaq.com/symbol/cnmd
adr_tso
EBITDA EBITDA(百万ドル) 125.32100
終値(lastsale) 73.67
時価総額(marketcap) 2070919320.85
時価総額 時価総額(百万ドル) 259.956
売上高 売上高(百万ドル) 827.55600
企業価値(EV) 企業価値(EV)(百万ドル) 2485.742
当期純利益 当期純利益(百万ドル) 41.36900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 CONMED Corporation revenues increased 8% to $414.9M. Net income increased from $1.6M to $19.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Restructuring decrease from $19M (expense) to $0K Derivatives increase from $1.8M to $5.9M (income) Restructuring - COGS decrease from $1.5M (expense) to $0K.

 CNMDのテクニカル分析


 CNMDのニュース

   CONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference  2020/09/03 20:05:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President, Chief Executive Officer and Chair of the Board, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference at 3:30 p.m. ET on Wednesday, September 16, 2020. A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.conmed.com
   Global ENT Endoscopic Surgery Devices Market (2019 to 2024) - Featuring Acclarent, Conmed & Entellus Among Others - ResearchAndMarkets.com  2020/08/28 09:48:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global ENT Endoscopic Surgery Devices Market" report has been added to ResearchAndMarkets.com's offering. This report was developed using extensive primary and secondary research by the publisher's analysts. Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of 2019 worldwide market size by product segment, ASPs, sales, and market
   Impact of COVID-19 on the Surgical Energy Generators Market 2020-2030 - ResearchAndMarkets.com  2020/08/17 09:17:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Surgical Energy Generators (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on Surgical Energy Generators market for the year 2020 and beyond. Companies Mentioned Medtronic plc Ethicon Inc. Olympus Corp. Conmed Corp. Stryker Corp. ERBE Elektromedizin GmbH Each of the covered 39 country's color-coded and full
   CONMED Corporation Announces Quarterly Cash Dividend  2020/08/13 20:05:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2020 to all shareholders of record as of September 15, 2020. About CONMED Corporation CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedi
   Endoscopy Fluid Management Systems Market, 2020-2030: Implications of the COVID-19 Pandemic - ResearchAndMarkets.com  2020/08/12 12:55:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Endoscopy Fluid Management Systems (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering. This market model discusses in detail the impact of COVID-19 on Endoscopy Fluid Management Systems market for the year 2020 and beyond. Companies Mentioned Stryker Corporation B. Braun Melsungen AG Hologic Inc. Olympus Corp. ConMed Corporation KARL STORZ GmbH & Co. KG W.O.M. World
   CONMED Corporation to Announce Second Quarter 2020 Financial Results on July 29, 2020  2020/07/01 20:05:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter of 2020 after the market close on Wednesday, July 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 1-844-889-7792 (domestic) or +1-661-378-9936 (international) and refer to the passcode 2083716. This conference call will also be webcast and can be
   COVID-19: Significant Shift in Strategy of Orthopedic Implants Market 2020-2024 | Rising Prevalence of Orthopedic Conditions to Augment Growth | Technavio  2020/06/25 23:50:00 Benzinga Feeds
Technavio has been monitoring the orthopedic implants market and it is poised to grow by USD 10.09 billion during 2020-2024, progressing at a CAGR of over 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200625005787/en/ Technavio has announced its latest market research report titled Global Orthopedic Implants Market 2020-2024 (Graphic: Business Wire). Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio's in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.
   Global Ligation Devices Market Outlook (2019 to 2027) - Featuring Medtronic, Conmed & Olympus Among Others - ResearchAndMarkets.com  2020/06/24 09:19:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Ligation Devices - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Ligation Devices market accounted for $876.00 million in 2019 and is expected to reach $1,657.80 million by 2027 growing at a CAGR of 8.3% during the forecast period. Some of the key factors propelling market growth are rise in several surgeries and increased incidence of chronic diseases. However, the high cost of the devices is the restrain
   COVID-19 Impact and Recovery Analysis- Knee Reconstruction Market 2020-2024 | Increasing Incidence of Knee Injuries to Boost Growth | Technavio  2020/06/03 21:45:00 Benzinga Feeds
Technavio has been monitoring the knee reconstruction market and it is poised to grow by USD 2.10 billion during 2020-2024, progressing at a CAGR of over 4% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200603005562/en/ Technavio has announced its latest market research report titled Global Knee Reconstruction Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Request for Technavio's latest reports on directly and indirectly impacted markets. Market estimates include pre- and post-COVID-19 impact on the Knee Reconstruction Market Download free sample report The market is moderately fragmented, and the degree of fragmentation will accelerate during the forecast period.
   Here's Why You Should Retain CONMED (CNMD) Stock for Now  2020/05/28 04:11:00 Zacks Investment Research
CONMED (CNMD) continues to benefit from broad product portfolio and persistent focus on R&D. However, forex remains a woe.
   COVID-19 Impact and Recovery Analysis- Knee Reconstruction Market 2020-2024 | Increasing Incidence of Knee Injuries to Boost Growth | Technavio  2020/06/03 21:45:00 Benzinga Feeds
Technavio has been monitoring the knee reconstruction market and it is poised to grow by USD 2.10 billion during 2020-2024, progressing at a CAGR of over 4% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200603005562/en/ Technavio has announced its latest market research report titled Global Knee Reconstruction Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Request for Technavio's latest reports on directly and indirectly impacted markets. Market estimates include pre- and post-COVID-19 impact on the Knee Reconstruction Market Download free sample report The market is moderately fragmented, and the degree of fragmentation will accelerate during the forecast period.
   Here's Why You Should Retain CONMED (CNMD) Stock for Now  2020/05/28 04:11:00 Zacks Investment Research
CONMED (CNMD) continues to benefit from broad product portfolio and persistent focus on R&D. However, forex remains a woe.
   CONMED Corporation Announces That 2020 Annual Meeting of Shareholders Will Be Virtual-Only Meeting Due to COVID-19  2020/05/11 11:00:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its 2020 Annual Meeting of Shareholders, scheduled for May 21, 2020, at 1:30 p.m. ET, will be hosted as a virtual-only meeting due to public health concerns and social-distancing restrictions imposed by governmental authorities with respect to non-essential gatherings arising from the COVID-19 pandemic. Information about the virtual meeting webcast and instructions for how shareholders can participate in the Annu
   Outlook into the Worldwide Electrosurgery Devices Industry to 2025 - Featuring Johnson & Johnson, Conmed & Stryker Among Others - ResearchAndMarkets.com  2020/05/07 13:17:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Electrosurgery Devices Market By Product (Electrosurgical Generators, Electrosurgical Instruments, Accessories), By Application, By End-user, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering. The Global Electrosurgery Devices Market is expected to grow at a steady rate during the forecast period. Growing trend of plastic surgeries, initiated by the celebrities to look younger has influenced a large par
   CONMED Corporation to Present at the BofA Securities Virtual Healthcare Conference  2020/05/04 20:05:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the BofA Securities Virtual Healthcare Conference at 9:40 a.m. ET on Tuesday, May 12, 2020. A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.conmed.com and will be available for replay following the ev

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 コンメド CNMD CONMED Corporation)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)